公司指南

Abridge 和 AI 臨床文檔

Abridge is a health AI company whose ambient documentation software listens to a consented doctor-patient visit and drafts a clinical note for the clinician to review and sign.

聆聽此指南AI 語音敘述 · ~7 min

本頁8 分鐘閱讀
  1. 概述
  2. 重點摘要
  3. 深入探討
  4. Auditing one AI-drafted note against its source
  5. 現實世界的實施
  6. The Future of Abridge and AI Clinical Documentation
  7. 付諸實踐
  8. 資料來源與延伸閱讀
  9. 不斷探索
  10. 常見問題

概述

It matters because documentation is a major source of clinician workload, and a 2025 JAMA Network Open study of its tool found burnout fell from 51.9% to 38.8% after 30 days.

重點摘要

  1. Abridge records consented clinical visits and drafts a structured note that the clinician must review, edit and sign before it enters the record.
  2. Kaiser Permanente rolled Abridge out to 40 hospitals and more than 600 medical offices in August 2024 after testing and review.
  3. A 2025 JAMA Network Open study of 263 clinicians found burnout fell from 51.9% to 38.8% after 30 days of using Abridge.
  4. That study had no control group and relied on self-reported surveys, so it shows association rather than proven cause.
  5. Abridge says each part of a draft note can be checked against the original transcript and audio, which helps clinicians catch errors.

深入探討

Abridge is a company that builds ambient clinical documentation, a category of software sometimes called an AI scribe. During a medical visit, with the patient's permission, the software records the conversation between clinician and patient. Afterward, it turns that recording into a draft of the clinical note, the formal record of symptoms, findings, assessment and plan that clinicians must write for every encounter. The clinician reviews, edits and signs the note, which is then filed in the electronic health record (EHR). The aim is to let clinicians look at the patient instead of a keyboard and to reduce the hours spent finishing notes after the clinic closes. Abridge's CEO and cofounder, Shiv Rao, is a practicing cardiologist, according to Fortune.

The process works in stages. First, the clinician starts a recording on a phone or in the EHR once the patient has agreed. Second, automatic speech recognition, which Abridge says is tuned for medical conversations, cross-talk and background noise, converts the audio into a transcript. Third, summarization pipelines that combine large language models with Abridge's own datasets and methods turn the transcript into a structured note organized into standard sections. Fourth, Abridge says it ties each span of the summary to supporting evidence in the conversation, so a clinician can check any sentence against the transcript and audio. Finally, the clinician edits and signs, and the note, along with other outputs such as patient summaries and billing-relevant detail, is placed in the chart.

Abridge's growth tracks the rapid adoption of this category. In August 2023 it became the first company in Epic's new Pals program, the developer program that replaced Epic's App Market, which allowed its tool to work inside Epic workflows. On August 14, 2024, Kaiser Permanente announced it was making Abridge available to clinicians at its 40 hospitals and more than 600 medical offices, after testing and quality review. Fortune reported in July 2025 that Abridge raised a 300 million dollar Series E led by Andreessen Horowitz with Khosla Ventures participating, at a 5.3 billion dollar valuation, up from 2.75 billion at its Series D, and that it was used in more than 150 enterprise health systems. Abridge's own website now says it is used by more than 300 health systems and powers more than 100 million conversations a year.

The strongest published evidence on outcomes is a quality improvement study in JAMA Network Open, published October 2, 2025, led by Kristine D. Olson of Yale School of Medicine. It surveyed ambulatory physicians and advanced practice clinicians at six US health systems before and 30 days after they began using the same version of the Abridge scribe, from February to October 2024. Among 263 clinicians analyzed, burnout fell from 51.9% to 38.8%. Clinicians also reported lower note-related cognitive load, better focused attention on patients, and 0.90 fewer hours per week of after-hours documentation. The intervention was funded by the participating institutions, and Abridge provided pooled survey data but had no role in design or analysis.

Those results come with real limits that the authors spell out. There was no control group, so changes over time or enthusiasm for a new tool could explain some of the improvement. Participants volunteered and responses were not anonymous, which may favor early adopters and positive answers. Outcomes were self-reported rather than measured from EHR activity logs, one site was excluded from the burnout analysis, and several authors disclosed ties to Abridge, including a current senior director. Customer-reported figures on Abridge's website, such as an 86% reduction in documentation effort at one health system, are company marketing claims rather than independent studies.

Compared with alternatives, ambient AI sits between older approaches. Clinicians can type notes themselves, which is accurate but time-consuming. Dictation software transcribes what the clinician says word for word but still requires them to compose the note. Human medical scribes, in the room or remote, can produce good notes but are expensive and hard to staff. Ambient AI tries to provide a scribe's output at software cost. Abridge's main differentiators, by its own account, are tight EHR integration and its traceability from note text back to the source conversation.

The risks are those of any generative AI applied to medical records. A language model can omit something important, attribute a statement to the wrong speaker, or confabulate, meaning produce plausible text that was never said; Abridge itself has published work on confabulation elimination, which acknowledges the problem. Because a signed note becomes a legal and clinical record, the clinician remains responsible for its accuracy, and review takes real attention. Recording patient conversations raises privacy and consent issues, which is why Kaiser Permanente requires patient agreement and Abridge states that it encrypts data and complies with state and federal privacy laws. Accuracy can also vary with accents, languages, noisy rooms and specialties.

In practice, adopting Abridge is an enterprise decision rather than an individual purchase. Health systems contract with the company, connect it to their EHR, set consent workflows, train clinicians, and monitor quality, often starting with pilots, as Kaiser Permanente did with testing before its 2024 rollout. Abridge also sells revenue-cycle features that aim to make documentation billing-ready, which links the product to coding and reimbursement and calls for compliance oversight. For patients, the visible change is usually a consent request at the start of a visit and, in some cases, a plain-language visit summary afterward.

04工作範例

Auditing one AI-drafted note against its source

  1. Pick a signed-off visit where an ambient scribe drafted the note and the transcript is available.

  2. List every medication, dose and allergy in the note.

  3. For each item, find the supporting moment in the transcript and confirm who said it and whether it was started, stopped or continued.

  4. List any clinically important facts from the transcript that are missing from the note.

  5. Mark any sentence in the note with no support in the transcript as a possible confabulation.

  6. Count supported items, omissions and unsupported sentences, and record how much editing the clinician did.

它顯示了什麼

A simple accuracy profile for that note: how many statements were grounded, missed or unsupported. Repeating this on a sample of visits across specialties and languages gives a health system its own quality evidence instead of relying only on vendor or survey data.

現實世界的實施

Kaiser Permanente made Abridge available to clinicians at 40 hospitals and more than 600 medical offices in eight states and Washington, D.C., in August 2024, requiring patient consent and clinician review of every note.

Working inside Epic: in August 2023 Abridge became the first company in Epic's Pals program for third-party developers, letting its notes flow into Epic clinical workflows instead of a separate app.

Checking a draft note: Abridge says clinicians can validate each part of a generated note against the underlying conversation transcript and audio recording before signing.

Nursing documentation: Abridge offers a nursing product that turns nurse-patient conversations into draft documentation, alongside its physician and revenue-cycle products.

Multilingual visits: Abridge states its speech recognition covers more than 14 languages, and customer AltaMed reports use across 28 languages at more than 60 centers.

The Future of Abridge and AI Clinical Documentation

The direction of the field is visible in Abridge's own product changes: from drafting physician notes toward nursing documentation, billing-ready coding detail, pre-visit summaries and in-visit prompts such as its Care Signals feature, which aims to ensure relevant conditions are addressed during the visit. Each step moves the software closer to clinical decision-making and reimbursement, raising the stakes of errors and the need for oversight. The main open question is evidence. The October 2025 JAMA Network Open study reported large drops in self-reported burnout after 30 days but had no control group, a limitation its authors state directly. Controlled trials that measure note accuracy, patient outcomes, billing effects and long-term clinician well-being are needed to judge whether early gains hold. Regulation and payer policy for AI-generated documentation are still developing. How Abridge's integration and traceability features compare with other ambient documentation products over time is also not settled.

付諸實踐

為什麼這很重要

  • 供應商策略. 供應商路線圖會影響您的團隊接下來可以建立的功能。
  • 成本與預算. 商業條款和部署選項會影響長期成本和風險。
  • 風險與安全. 公司激勵措施塑造了產品預設、安全態勢和開放性。

留意

  • 發佈公告可能會超過實際生產工作流程的穩定性。
  • API 定價或政策轉變可能會在一夜之間打破假設。
  • 單一供應商依賴性增加了鎖定和遷移成本。

後續步驟

  1. 使用您自己的任務和資料集評估提供者。
  2. 在整合之前查看隱私、安全和法律條款。
  3. 維護跨模型或供應商的後備計劃。
  4. 監控發行說明,以便路線圖的變更不會讓團隊感到意外。

資料來源與延伸閱讀

  1. JAMA Network Open (via PubMed Central)Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout
  2. Kaiser PermanenteKaiser Permanente improves member experience with AI-enabled clinical technology
  3. Healthcare DiveEpic, AI startup Abridge partner in third-party developer program
  4. FortuneAbridge CEO Shiv Rao on raising $300 million, a prospective IPO, and the future of healthcare
  5. AbridgeAbridge
  6. AbridgeAI at Abridge

不斷探索

免費電子報

獲取每日 AI 簡報

每個工作日上午提供三則經過驗證的 AI 新聞,以淺顯易懂的英文撰寫。永久免費,無廣告。

每個工作日一封電子郵件。一鍵取消訂閱。我們絕不出售或分享您的地址。

測試一下自己

Take the Abridge and AI Clinical Documentation quiz

每個答案皆有即時回饋,通過課程後可獲得具備可驗證 ID 的可分享證書。

開始測驗

支持免費的 AI 教育。AI Understanding 是一個 501(c)(3) 非營利組織——絕無廣告,絕無付費牆。 捐款

常見問題

What is Abridge and AI Clinical Documentation?

Abridge is a health AI company whose ambient documentation software listens to a consented doctor-patient visit and drafts a clinical note for the clinician to review and sign. It matters because documentation is a major source of clinician workload, and a 2025 JAMA Network Open study of its tool found burnout fell from 51.9% to 38.8% after 30 days.

Abridge 主要是為了解決什麼問題?

Abridge 透過自動化臨床記錄來應對繁重的筆記書寫工作量,這種工作量會導致醫生倦怠。

在 Abridge 的上下文中「環境」是什麼意思?

環境人工智慧以不引人注目的方式捕捉自然的醫病對話,而不需要結構化聽寫。

哪些獨特的功能讓臨床醫師信任 Abridge 的輸出?

Abridge 將生成的文本映射到其來源音頻,讓臨床醫生驗證任何陳述——這是一個關鍵的信任和問責功能。

Abridge 是誰創立的,背景是什麼?

Abridge 由執業心臟科醫生 Shiv Rao 於 2018 年創立。

Abridge 如何融入現有的醫院工作流程?

深度 EHR 整合意味著筆記會自動流入 Epic 等系統中的病患病歷中。